Haemodynamic effects of nifedipine and propranolol in patients with hypertrophic obstructive cardiomyopathy.
Open Access
- 1 July 1982
- Vol. 48 (1) , 19-26
- https://doi.org/10.1136/hrt.48.1.19
Abstract
The haemodynamic effects of nifedipine, propranolol, and the combined administration of the two drugs were studied in 12 patients with hypertrophic obstructive cardiomyopathy. The combined administration of nifedipine and propranolol appeared to be superior to that of nifedipine alone. The spontaneous heart rate was reduced in most cases after nifedipine plus propranolol, and at atrial pacing the following results were obtained: left ventricular peak systolic pressure was reduced from 200 +/- 39 to 157 +/- 30 mmHg; a positive correlation was found between the pre-drug left ventricular end-diastolic pressure and the magnitude of reduction in left ventricular end-diastolic pressure; systolic blood pressure was reduced from 125 +/- 31 to 111 +/- 27 mmHg, and total peripheral resistance was reduced from 1403 +/- 307 to 1160 +/- 209 dyne s-1 cm-5. The combined administration reduced the resting left ventricular outflow gradient from 76 +/- 19 to 45 +/- 26 mmHg, while cardiac index was left unchanged. The effects on mean pulmonary arteriolar resistance and mean pulmonary arteriolar resistance and mean pulmonary capillary venous pressure were in most cases slight and insignificant. The results indicate an improved haemodynamic condition in patients with hypertrophic obstructive cardiomyopathy after the combined administration of nifedipine and propranolol: a treatment that might provide a new and useful alternative to already existing medication.Keywords
This publication has 43 references indexed in Scilit:
- Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy.Circulation, 1981
- Improved Diastolic Function and Systolic Performance in Hypertrophic Cardiomyopathy after NifedipineNew England Journal of Medicine, 1980
- Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status.Circulation, 1979
- Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects.Circulation, 1979
- Treatment of hypertension with nifedipine, a calcium antagonistic agent.Circulation, 1979
- EFFECTS OF NIFEDIPINE ON BLOOD PRESSURE, REGIONAL HEMODYNAMICS, PLASMA RENIN ACTIVITY AND PLASMA CATECHOLAMINES IN PATIENTS WITH ARTERIAL HYPERTENSION.Acta Medica Scandinavica, 1979
- Calcium‐antagonistic and Anti‐arrhythmic Effects of Nifedipine on the Isolated Rat AtriumActa Pharmacologica et Toxicologica, 1975
- Muscular Subaortic StenosisCirculation, 1968
- Amelioration of Angina Pectoris in Idiopathic Hypertrophic Subaortic Stenosis with Beta-Adrenergic BlockadeCirculation, 1967
- Effects of Beta Adrenergic Blockade on the Circulation, with Particular Reference to Observations in Patients with Hypertrophic Subaortic StenosisCirculation, 1964